{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:25:18Z","timestamp":1759991118112,"version":"3.44.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T00:00:00Z","timestamp":1688860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.rcsop.2023.100307","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T21:24:26Z","timestamp":1689024266000},"page":"100307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Assessing treatment switch among patients with multiple sclerosis: A machine learning approach"],"prefix":"10.1016","volume":"11","author":[{"given":"Jieni","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George J.","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajender R.","family":"Aparasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcsop.2023.100307_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/B978-0-444-52001-2.00002-9","article-title":"Pathology of multiple sclerosis and related inflammatory demyelinating diseases","volume":"122","author":"Kutzelnigg","year":"2014","journal-title":"Handb Clin Neurol"},{"issue":"10","key":"10.1016\/j.rcsop.2023.100307_bb0010","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007035","article-title":"The prevalence of MS in the United States","volume":"92","author":"Wallin","year":"2019","journal-title":"Neurology."},{"issue":"8","key":"10.1016\/j.rcsop.2023.100307_bb0015","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of multiple sclerosis","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMA."},{"issue":"6 Suppl","key":"10.1016\/j.rcsop.2023.100307_bb0020","first-page":"s141","article-title":"Overview and diagnosis of multiple sclerosis","volume":"22","author":"Hunter","year":"2016","journal-title":"Am J Manag Care"},{"issue":"2","key":"10.1016\/j.rcsop.2023.100307_bb0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.msard.2013.09.004","article-title":"Burden of multiple sclerosis on direct, indirect costs and quality of life: national US estimates","volume":"3","author":"Campbell","year":"2014","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"10.1016\/j.rcsop.2023.100307_bb0030","first-page":"741","article-title":"Marginal health care expenditure burden among US civilian noninstitutionalized individuals with multiple sclerosis: 2010-2015","volume":"26","author":"Earla","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.rcsop.2023.100307_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104019","article-title":"Health-related quality of life of patients with multiple sclerosis: analysis of ten years of national data","volume":"66","author":"Li","year":"2022","journal-title":"Mult Scler Relat Disord"},{"issue":"17","key":"10.1016\/j.rcsop.2023.100307_bb0040","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1212\/WNL.0000000000005347","article-title":"Practice guideline recommendations summary: disease-modifying therapies for adults with multiple sclerosis","volume":"90","author":"Rae-Grant","year":"2018","journal-title":"Neurology."},{"issue":"10076","key":"10.1016\/j.rcsop.2023.100307_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(16)32388-1","article-title":"Evolving concepts in the treatment of relapsing multiple sclerosis","volume":"389","author":"Comi","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.rcsop.2023.100307_bb0050","first-page":"74","article-title":"Expenditure, utilization, and cost of specialty drugs for multiple sclerosis in the US Medicaid population, 2008-2018","volume":"13","author":"Elsisi","year":"2020","journal-title":"Am Health Drug Benefits"},{"issue":"7","key":"10.1016\/j.rcsop.2023.100307_bb0055","doi-asserted-by":"crossref","first-page":"545","DOI":"10.12998\/wjcc.v3.i7.545","article-title":"Treatment strategies for multiple sclerosis: when to start, when to change, when to stop?","volume":"3","author":"Gajofatto","year":"2015","journal-title":"World J Clin Cases"},{"issue":"17","key":"10.1016\/j.rcsop.2023.100307_bb0060","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005399","article-title":"Complexity of MS management in the current treatment era","volume":"90","author":"Chitnis","year":"2018","journal-title":"Neurology."},{"issue":"9","key":"10.1016\/j.rcsop.2023.100307_bb0065","doi-asserted-by":"crossref","DOI":"10.1177\/1352458518790390","article-title":"Determinants of therapy switch in multiple sclerosis treatment-na\u00efve patients: a real-life study","volume":"25","author":"Sacc\u00e0","year":"2019","journal-title":"Mult Scler J"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100307_bb0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/CPJ.0b013e31823cc2b0","article-title":"Multiple sclerosis therapeutic strategies: start safe and effective, reassess early, and escalate if necessary","volume":"1","author":"Naismith","year":"2011","journal-title":"Neurol Clin Pract"},{"author":"Milliman Client Report","key":"10.1016\/j.rcsop.2023.100307_bb0075"},{"issue":"4","key":"10.1016\/j.rcsop.2023.100307_bb0080","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s40801-021-00251-w","article-title":"Retrospective Claims Analysis of Treatment Patterns, Relapse, Utilization, and Cost Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy","volume":"8","author":"Freeman","year":"2021","journal-title":"Drugs Real World Outcomes"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100307_bb0085","article-title":"Utilization patterns of Oral disease-modifying drugs in commercially insured patients with multiple sclerosis","volume":"25","author":"Desai","year":"2019","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.rcsop.2023.100307_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103703","article-title":"Factors associated with switching from injectable to oral disease modifying agents among patients with multiple sclerosis","volume":"60","author":"Li","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.rcsop.2023.100307_bb0095","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/j.wneu.2017.12.029","article-title":"Predictive value of intraoperative facial motor evoked potentials in vestibular schwannoma surgery under 2 anesthesia protocols","volume":"111","author":"Ling","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1016\/j.rcsop.2023.100307_bb0100","series-title":"2014 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)","first-page":"556","article-title":"Deep learning for healthcare decision making with EMRs","author":"Liang","year":"2014"},{"issue":"2\u20134","key":"10.1016\/j.rcsop.2023.100307_bb0105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1504\/IJBET.2017.087722","article-title":"A survey of big data architectures and machine learning algorithms in healthcare","volume":"25","author":"Manogaran","year":"2017","journal-title":"Int J Biomed Eng Technol"},{"issue":"5","key":"10.1016\/j.rcsop.2023.100307_bb0110","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s10143-019-01163-8","article-title":"Machine learning applications to clinical decision support in neurosurgery: an artificial intelligence augmented systematic review","volume":"43","author":"Buchlak","year":"2020","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.rcsop.2023.100307_bb0115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.yebeh.2015.12.039","article-title":"Changing the approach to treatment choice in epilepsy using big data","volume":"56","author":"Devinsky","year":"2016","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.rcsop.2023.100307_bb0120","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.21660","article-title":"Development and validation of a machine learning individualized treatment rule in first-episode schizophrenia","volume":"3","author":"Wu","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.rcsop.2023.100307_bb0125","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.wneu.2017.09.149","article-title":"Machine learning and neurosurgical outcome prediction: a systematic review","volume":"109","author":"Senders","year":"2018","journal-title":"World Neurosurg"},{"issue":"2","key":"10.1016\/j.rcsop.2023.100307_bb0130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/life11020122","article-title":"Machine learning use for prognostic purposes in multiple sclerosis","volume":"11","author":"Seccia","year":"2021","journal-title":"Life."},{"issue":"1","key":"10.1016\/j.rcsop.2023.100307_bb0135","first-page":"E192","article-title":"Prediction of multiple sclerosis disease using machine learning classifiers: a comparative study","volume":"62","author":"Darvishi","year":"2021","journal-title":"J Prev Med Hyg"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100307_bb0140","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1038\/s41467-021-22265-2","article-title":"Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data","volume":"12","author":"Eshaghi","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.rcsop.2023.100307_bb0145","article-title":"A systematic review of the application of machine-learning algorithms in multiple sclerosis","author":"V\u00e1zquez-Marrufo","year":"2021","journal-title":"Neurologia (Engl Ed)"},{"issue":"5","key":"10.1016\/j.rcsop.2023.100307_bb0150","doi-asserted-by":"crossref","DOI":"10.1111\/jch.13531","article-title":"First-line treatment of essential hypertension: a real-world analysis across four antihypertensive treatment classes","volume":"21","author":"Stapff","year":"2019","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.rcsop.2023.100307_bb0155","first-page":"27","article-title":"Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the US","author":"Ontaneda","year":"2019","journal-title":"Mult Scler Relat Disord"},{"issue":"10","key":"10.1016\/j.rcsop.2023.100307_bb0160","doi-asserted-by":"crossref","first-page":"e1016","DOI":"10.1212\/WNL.0000000000007043","article-title":"Validation of an algorithm for identifying MS cases in administrative health claims datasets","volume":"92","author":"Culpepper","year":"2019","journal-title":"Neurology."},{"key":"10.1016\/j.rcsop.2023.100307_bb0165","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.msard.2016.07.003","article-title":"Brain health: time matters in multiple sclerosis","volume":"9","author":"Giovannoni","year":"2016","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"10.1016\/j.rcsop.2023.100307_bb0170","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/CPJ.0000000000001045","article-title":"Multiple sclerosis phenotypes as a continuum","volume":"11","author":"Vollmer","year":"2021","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.rcsop.2023.100307_bb0175","series-title":"R Foundation for Statistical Computing, Vienna, Austria","article-title":"The caret package","author":"Kuhn","year":"2023"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100307_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/2137284","article-title":"Revisiting the behavioral model and access to medical care: does it matter?","volume":"36","author":"Andersen","year":"1995","journal-title":"J Health Soc Behav"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100307_bb0185","doi-asserted-by":"crossref","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100307_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-11-523","article-title":"Class prediction for high-dimensional class-imbalanced data","volume":"11","author":"Blagus","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.rcsop.2023.100307_bb0195","article-title":"Feature Selection in Imbalanced Data","author":"Kamalov","year":"2022","journal-title":"Ann. Data. Sci."},{"key":"10.1016\/j.rcsop.2023.100307_bb0200","series-title":"Proceedings of the AAAI\u20192000 Workshop on Imbalanced Data Sets","first-page":"1","article-title":"Machine learning from imbalanced data sets 101","volume":"vol. 68","author":"Provost","year":"2000"},{"issue":"8","key":"10.1016\/j.rcsop.2023.100307_bb0205","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1177\/0962280218784726","article-title":"Sample size for binary logistic prediction models: beyond events per variable criteria","volume":"28","author":"van Smeden","year":"2019","journal-title":"Stat Methods Med Res"},{"issue":"2","key":"10.1016\/j.rcsop.2023.100307_bb0210","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.patcog.2010.08.011","article-title":"Mining data with random forests: a survey and results of new tests","volume":"44","author":"Verikas","year":"2011","journal-title":"Pattern Recogn"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100307_bb0215","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach Learn"},{"issue":"4","key":"10.1016\/j.rcsop.2023.100307_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175383","article-title":"Use of a machine learning framework to predict substance use disorder treatment success","volume":"12","author":"Acion","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.rcsop.2023.100307_bb0225","series-title":"Using Random Forest to Learn Imbalanced Data","first-page":"24","volume":"110(1\u221212)","author":"Chen","year":"2004"},{"issue":"6","key":"10.1016\/j.rcsop.2023.100307_bb0230","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/CIRCOUTCOMES.116.003308","article-title":"Learning about machine learning: the promise and pitfalls of big data and the electronic health record","volume":"9","author":"Deo","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"10.1016\/j.rcsop.2023.100307_bb0235","first-page":"18","article-title":"Classification and regression by randomForest","volume":"2","author":"Liaw","year":"2002","journal-title":"R News"},{"issue":"3","key":"10.1016\/j.rcsop.2023.100307_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/widm.1301","article-title":"Hyperparameters and tuning strategies for random forest","volume":"9","author":"Probst","year":"2019","journal-title":"Wiley Interdiscip Rev Data Min Knowl Discov"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100307_bb0245","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.18962","article-title":"Comparison of machine learning methods with traditional models for use of administrative claims with electronic medical records to predict heart failure outcomes","volume":"3","author":"Desai","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.rcsop.2023.100307_bb0250","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics."},{"issue":"1","key":"10.1016\/j.rcsop.2023.100307_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw"},{"issue":"3","key":"10.1016\/j.rcsop.2023.100307_bb0260","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics."},{"key":"10.1016\/j.rcsop.2023.100307_bb0265","series-title":"Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach","volume":"44","author":"Delong","year":"1988"},{"key":"10.1016\/j.rcsop.2023.100307_bb0270","series-title":"Annual Proceedings on Reliability and Maintainability Symposium","first-page":"286","article-title":"Fault trees and sequence dependencies","author":"Dugan","year":"1990"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100307_bb0275","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12864-019-6413-7","article-title":"The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation","volume":"21","author":"Chicco","year":"2020","journal-title":"BMC Genomics"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100307_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12880-015-0068-x","article-title":"Metrics for evaluating 3D medical image segmentation: analysis, selection, and tool","volume":"15","author":"Taha","year":"2015","journal-title":"BMC Med Imaging"},{"issue":"2","key":"10.1016\/j.rcsop.2023.100307_bb0285","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1023\/A:1007452223027","article-title":"Machine learning for the detection of oil spills in satellite radar images","volume":"30","author":"Kubat","year":"1998","journal-title":"Mach Learn"},{"key":"10.1016\/j.rcsop.2023.100307_bb0290","series-title":"Beyond Accuracy, F-Score and ROC: A Family of Discriminant Measures for Performance Evaluation","first-page":"1015","author":"Sokolova","year":"2006"},{"year":"2017","series-title":"Predictive accuracy: a misleading performance measure for highly imbalanced data classified negative","author":"Josephine","key":"10.1016\/j.rcsop.2023.100307_bb0295"},{"key":"10.1016\/j.rcsop.2023.100307_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v028.i05","article-title":"Building predictive models in R using the caret package","volume":"28","author":"Kuhn","year":"2008","journal-title":"J Stat Softw"},{"key":"10.1016\/j.rcsop.2023.100307_bb0305","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jclinepi.2019.02.004","article-title":"A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models","volume":"110","author":"Christodoulou","year":"2019","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.rcsop.2023.100307_bb0310","series-title":"Proceedings of the 23rd International Conference on Machine Learning","first-page":"233","article-title":"The relationship between Precision-Recall and ROC curves","author":"Davis","year":"2006"},{"issue":"3","key":"10.1016\/j.rcsop.2023.100307_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118432","article-title":"The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets","volume":"10","author":"Saito","year":"2015","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.rcsop.2023.100307_bb0320","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1109\/TKDE.2008.239","article-title":"Learning from imbalanced data","volume":"21","author":"He","year":"2009","journal-title":"IEEE Trans Knowl Data Eng"},{"key":"10.1016\/j.rcsop.2023.100307_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107839","article-title":"Understanding opioid use disorder (OUD) using tree-based classifiers","volume":"208","author":"Wadekar","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.rcsop.2023.100307_bb0330","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/14737175.2021.1886082","article-title":"Considering patient age when treating multiple sclerosis across the adult lifespan","volume":"21","author":"Jakimovski","year":"2021","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100307_bb0335","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12883-021-02347-w","article-title":"Clinical characteristics of middle-aged and older patients with MS treated with interferon beta-1b: post-hoc analysis of a 2-year, prospective, international, observational study","volume":"21","author":"Patti","year":"2021","journal-title":"BMC Neurol"},{"issue":"12","key":"10.1016\/j.rcsop.2023.100307_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.sapharm.2020.02.016","article-title":"Use of disease modifying agents in patients with multiple sclerosis: analysis of ten years of national data","volume":"16","author":"Earla","year":"2020","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.rcsop.2023.100307_bb0345","doi-asserted-by":"crossref","DOI":"10.2147\/PPA.S270557","article-title":"Comparative adherence trajectories of Oral Fingolimod and injectable disease modifying agents in multiple sclerosis","volume":"14","author":"Earla","year":"2020","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100307_bb0350","doi-asserted-by":"crossref","DOI":"10.1007\/s40120-017-0064-x","article-title":"Comparative effectiveness research of disease-modifying therapies for the Management of Multiple Sclerosis: analysis of a large health insurance claims database","volume":"6","author":"Boster","year":"2017","journal-title":"Neurol Ther"},{"issue":"4","key":"10.1016\/j.rcsop.2023.100307_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinthera.2015.03.001","article-title":"New FDA-approved disease-modifying therapies for multiple sclerosis","volume":"37","author":"English","year":"2015","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.rcsop.2023.100307_bb0360","doi-asserted-by":"crossref","DOI":"10.1136\/practneurol-2015-001139","article-title":"Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis","volume":"15","author":"Scolding","year":"2015","journal-title":"Pract Neurol"},{"key":"10.1016\/j.rcsop.2023.100307_bb0365","first-page":"2013","article-title":"Body mass index in multiple sclerosis: associations with CSF neurotransmitter metabolite levels","author":"Markianos","year":"2013","journal-title":"Int Sch Res Notices"},{"issue":"7","key":"10.1016\/j.rcsop.2023.100307_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.29245\/2572.942X\/2016\/7.1064","article-title":"Obesity and multiple sclerosis susceptibility: a review","volume":"1","author":"Gianfrancesco","year":"2016","journal-title":"J Neurol Neuromed"},{"issue":"24","key":"10.1016\/j.rcsop.2023.100307_bb0375","doi-asserted-by":"crossref","first-page":"e2256","DOI":"10.1212\/WNL.0000000000006644","article-title":"Body mass index, but not vitamin D status, is associated with brain volume change in MS","volume":"91","author":"Mowry","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.rcsop.2023.100307_bb0380","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jneuroim.2015.09.008","article-title":"Body mass index influence interferon-beta treatment response in multiple sclerosis","volume":"288","author":"Kvistad","year":"2015","journal-title":"J Neuroimmunol"},{"issue":"9","key":"10.1016\/j.rcsop.2023.100307_bb0385","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1080\/01616412.2019.1622873","article-title":"Body mass index in patients with multiple sclerosis: a meta-analysis","volume":"41","author":"Dardiotis","year":"2019","journal-title":"Neurol Res"},{"issue":"16 Supplement","key":"10.1016\/j.rcsop.2023.100307_bb0390","article-title":"Development of an algorithm to identify multiple sclerosis (MS) disease severity based on healthcare costs in a US Administrative Claims Database (P2.052)","volume":"88","author":"Nicholas","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.rcsop.2023.100307_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102741","article-title":"Use of a claims-based algorithm to estimate disease severity in the multiple sclerosis Medicare population","volume":"49","author":"Toliver","year":"2021","journal-title":"Mult Scler Relat Disord"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276623000884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276623000884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T08:30:52Z","timestamp":1757406652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276623000884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":79,"alternative-id":["S2667276623000884"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2023.100307","relation":{},"ISSN":["2667-2766"],"issn-type":[{"type":"print","value":"2667-2766"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing treatment switch among patients with multiple sclerosis: A machine learning approach","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2023.100307","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100307"}}